Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study

Hans Christian Ring; Jonathan Thorsen; Brian Kirby; John R Ingram; Nana Aviaaja Lippert Rosenø; Nikolaj Holgersen; Valdemar W Nielsen; David Nikolai Thein Aagaard; Julia-Tatjana Maul; Jashin J Wu; Jacob P Thyssen; Alexander Egeberg; Simon F Thomsen

doi:10.1093/bjd/ljae042

Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study

Hans Christian Ring^*, Jonathan Thorsen, Brian Kirby, John R Ingram, Nana Aviaaja Lippert Rosenø, Nikolaj Holgersen, Valdemar W Nielsen, David Nikolai Thein Aagaard, Julia-Tatjana Maul, Jashin J Wu, Jacob P Thyssen, Alexander Egeberg, Simon F Thomsen

^*Corresponding author for this work

8 Citations (Scopus)

Original language	English
Journal	British Journal of Dermatology
Volume	190
Issue number	5
Pages (from-to)	769-771
Number of pages	3
ISSN	0007-0963
DOIs	https://doi.org/10.1093/bjd/ljae042
Publication status	Published - 17 Apr 2024

Keywords

Humans
Adalimumab
Ustekinumab
Infliximab
Hidradenitis Suppurativa
Cohort Studies
Denmark
Antibodies, Monoclonal, Humanized

Access to Document

10.1093/bjd/ljae042

Cite this

Ring, H. C., Thorsen, J., Kirby, B., Ingram, J. R., Rosenø, N. A. L., Holgersen, N., Nielsen, V. W., Thein Aagaard, D. N., Maul, J.-T., Wu, J. J., Thyssen, J. P., Egeberg, A., & Thomsen, S. F. (2024). Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study. British Journal of Dermatology, 190(5), 769-771. https://doi.org/10.1093/bjd/ljae042

Ring, HC, Thorsen, J, Kirby, B, Ingram, JR, Rosenø, NAL , Holgersen, N , Nielsen, VW, Thein Aagaard, DN, Maul, J-T, Wu, JJ, Thyssen, JP , Egeberg, A & Thomsen, SF 2024, 'Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study', British Journal of Dermatology, vol. 190, no. 5, pp. 769-771. https://doi.org/10.1093/bjd/ljae042

@article{9d0cbdfe3fc3448db6ef90ef34c8011b,

title = "Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study",

keywords = "Humans, Adalimumab, Ustekinumab, Infliximab, Hidradenitis Suppurativa, Cohort Studies, Denmark, Antibodies, Monoclonal, Humanized",

author = "Ring, \{Hans Christian\} and Jonathan Thorsen and Brian Kirby and Ingram, \{John R\} and Rosen{\o}, \{Nana Aviaaja Lippert\} and Nikolaj Holgersen and Nielsen, \{Valdemar W\} and \{Thein Aagaard\}, \{David Nikolai\} and Julia-Tatjana Maul and Wu, \{Jashin J\} and Thyssen, \{Jacob P\} and Alexander Egeberg and Thomsen, \{Simon F\}",

year = "2024",

month = apr,

day = "17",

doi = "10.1093/bjd/ljae042",

language = "English",

volume = "190",

pages = "769--771",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa

T2 - a Danish nationwide cohort study

AU - Ring, Hans Christian

AU - Thorsen, Jonathan

AU - Kirby, Brian

AU - Ingram, John R

AU - Rosenø, Nana Aviaaja Lippert

AU - Holgersen, Nikolaj

AU - Nielsen, Valdemar W

AU - Thein Aagaard, David Nikolai

AU - Maul, Julia-Tatjana

AU - Wu, Jashin J

AU - Thyssen, Jacob P

AU - Egeberg, Alexander

AU - Thomsen, Simon F

PY - 2024/4/17

Y1 - 2024/4/17

KW - Humans

KW - Adalimumab

KW - Ustekinumab

KW - Infliximab

KW - Hidradenitis Suppurativa

KW - Cohort Studies

KW - Denmark

KW - Antibodies, Monoclonal, Humanized

UR - https://www.scopus.com/pages/publications/85190902734

U2 - 10.1093/bjd/ljae042

DO - 10.1093/bjd/ljae042

M3 - Letter

C2 - 38305415

SN - 0007-0963

VL - 190

SP - 769

EP - 771

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 5

ER -

Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study

Keywords

Access to Document

Other files and links

Cite this